Skip to content

A multicenter cohort study on tuberculosis

A multicenter cohort study on tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082423
Enrollment
Unknown
Registered
2024-03-28
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis, Latent infected of tuberculosis

Interventions

TB Group:None
Latent infection of tuberculosis Group (Developing into active tuberculosis/Not developing into active tuberculosis):None

Sponsors

The Third People's Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: Part 1: 1: Tuberculosis cases registered in HIS from January 1, 2019 to December 31, 2023 2: Mycobacterium tuberculosis infection with positive bacterial culture results 3: At least one drug sensitivity test result 4: Complete clinical data and address data 5: Retain complete clinical samples or strains Part 2: ? The first sputum bacteriological culture result was positive and confirmed as Mycobacterium tuberculosis infection; ? Positive sputum bacteria at the end of June; ? Preserve the bacterial strains and clinical data at the end of treatment months 0 and 3; ? Follow up on bacterial strains and clinical data at the end of 9, 12, 18, and 24 months; ? Be aware of the research purpose and voluntarily participate in the study. Part 3: ? Positive skin test for tuberculin (excluding BCG vaccination reaction) or interferon ? Positive release test; ? Clinical symptoms of inactive tuberculosis; ? No tuberculous lesions were found on imaging; ? Phlegm bacteriology is negative.

Exclusion criteria

Exclusion criteria: 1: Infants and young children under 1 year old 2: Pregnant and lactating women 3: Human immunodeficiency virus infection with a positive result 4: Patients who are unwilling to provide personal information or whose clinical samples cannot be utilized

Design outcomes

Primary

MeasureTime frame
Sputum bacterial positivity rate;Sputum negative conversion rate;Incidence rate of tuberculosis;

Countries

China

Contacts

Public ContactShuihua Lu

The Third People's Hospital of Shenzhen

lushuihua66@126.com+86 189 3081 1818

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026